Ahabir

Description:

Ahabir is an oral hormonal therapy used in the treatment of metastatic castration-resistant prostate cancer. It contains abiraterone acetate, which blocks the enzyme CYP17 to inhibit androgen production-a key driver of prostate cancer.

Ahabir is used in combination with prednisone and has demonstrated improved survival in patients with advanced disease. Its targeted mechanism and effectiveness make it a standard of care for late-stage prostate cancer management.

Write to Us

Share your experience with our medical product. Write a review!

Blog

17 Nov 2025

Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma

When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.

Read More

17 Nov 2025

The Role of Lifestyle Modifications in Chronic Disease Prevention

Chronic diseases-like type 2 diabetes, heart disease, hypertension, and certain cancers-are no longer just problems for “other people.”

Read More

29 Sep 2025

Gut Health and Immunity: Why a Healthy Digestive System is Your First Line of Defense

When most people think of the immune system, they imagine white blood cells, vaccines, or medicines that protect the body from infections.

Read More

29 Sep 2025

The Future of Pain Relief: From Traditional Balms to Next-Gen Transdermal Patches

Pain is one of the most common reasons people seek medical attention, whether it’s muscle pain after a long day, joint pain due to arthritis, or chronic conditions that affect daily living.

Read More